I Did a DNA Health Test With AlphaBiolabs - Here's What It Revealed About My Risk Profile

I was skeptical about DNA health testing. The marketing promised revelations about disease risk, genetic predispositions, and personalised health strategies. In reality, most health DNA tests show you polygenic risk scores that tell you something you probably already knew: your lifestyle matters more than your genes.

But I took the AlphaBiolabs DNA health test anyway, partly to see what's actually actionable in the data, and partly because there are specific questions about genetics and health where DNA testing can genuinely provide useful information. For the separate, legally distinct world of paternity testing, see my UK paternity DNA testing guide for men.

Here's what I found, what surprised me, and what actually changed about how I approach my health.

What the Test Covers

AlphaBiolabs' DNA health test examines genetic markers across several categories:

• Cardiovascular disease risk (genetic variants affecting cholesterol, inflammation, thrombosis)
• Cancer predisposition (BRCA genes, other relevant variants)
• Metabolic health (diabetes, obesity genetics)
• Vitamin and nutrient metabolism (how your genes affect nutrient absorption and function)
• Pharmacogenomics (how your genes affect drug metabolism)
• Athletic traits (if you're interested in that angle)

The test itself is simple: order a kit, provide a saliva sample, mail it back, and get results within 3-4 weeks.

The Results: What Stood Out

My cardiovascular risk score came back as "moderate," with specific variants flagged:

• An LDL cholesterol-raising variant (relatively common)
• A variant affecting inflammatory markers
• A thrombosis-related variant

None of these were earth-shattering. My actual blood lipid profile is good (LDL 95 mg/dL, HDL 65, triglycerides 85), so the genetic predisposition isn't translating to actual risk at present. But the test identified that I carry genetic variants that could push me toward higher cholesterol if my lifestyle becomes less optimal (more processed food, less exercise, weight gain).

This was actually useful information: it meant I knew where I was genetically vulnerable. Even if my current labs are good, I can't be complacent about diet and exercise because my genetic background makes me predisposed to lipid dysfunction.

Cancer risk was reassuring: no BRCA variants, no predisposition to familial cancers. This doesn't mean cancer risk is zero, but it does mean my risk isn't driven by major genetic predispositions.

The metabolic health section showed no variants associated with diabetes or obesity risk. Again, not shocking given my health metrics, but it's useful to confirm genetically.

Pharmacogenomics: Where This Got Interesting

The pharmacogenomics section identified how my genes affect drug metabolism. Specifically, I'm a "rapid metaboliser" for certain drugs (CYP3A4 variants), meaning I metabolise some medications faster than average. This has implications if I ever need to take certain prescription drugs - standard doses might be subtherapeutic for me.

This isn't immediately actionable, but it's useful information to have in a medical file. If I ever need statins (unlikely given current lipids, but possible with age), or certain other medications, knowing I'm a rapid metaboliser means my doctor should consider higher-than-standard doses.

This is one of the few categories where DNA testing provides genuinely useful clinical information rather than risk estimates.

Nutrient Metabolism: The Surprising Part

The nutrient metabolism section revealed that I have a variant affecting MTHFR (methylenetetrahydrofolate reductase), the enzyme that converts folic acid to active methylfolate. It's not a severe polymorphism, but it suggests I may absorb synthetic folic acid less efficiently than someone without the variant.

This explained something I'd noticed: when I supplemented synthetic folic acid, I felt no particular benefit. When I switched to methylfolate (the active form), I noticed better energy and cognitive clarity. This genetic test confirmed why that difference existed.

I also carry variants affecting vitamin D receptor function, suggesting I may need slightly higher vitamin D supplementation for the same blood serum levels as someone without the variant. This is practically useful: my vitamin D supplementation needs to be on the higher end of the recommended range (3000-4000 IU) rather than 2000.

What Wasn't Useful

The test provided "polygenic risk scores" for various conditions: heart disease, type 2 diabetes, Alzheimer's. These scores place you in a percentile relative to the population (e.g., "higher than 65% of the population").

These are mostly not actionable. Everyone's at some genetic risk for common diseases. What matters far more is actual blood work (lipid panels, glucose), lifestyle (diet, exercise, sleep), and family history. The polygenic score adds minimal information beyond what you already know about yourself.

The athletic traits section was interesting but not particularly relevant to my goals. It showed I have some genetic variants associated with endurance performance, which aligns with my experience, but this doesn't change my training approach.

The Verdict: What Changed

The DNA test didn't reveal anything shocking, but it did provide useful confirmation and clarification in specific areas:

1. Cardiovascular risk: Knowing my genetic vulnerabilities motivated me to stay vigilant about diet and exercise, even though current labs are good. Prevention is easier than reversal.

2. Pharmacogenomics: Having this information documented means I can make better decisions about medication if needed in the future.

3. Nutrient metabolism: This justified my switch to methylfolate and higher vitamin D dosing. It's not dramatic, but it's more efficient than guessing.

4. Reassurance: Knowing I don't carry BRCA variants or major cancer predispositions is genuinely reassuring.

Practical Recommendations for DNA Testing

If you're considering DNA health testing:

1. Get it if: You have family history of genetic disease (BRCA, familial hypercholesterolaemia), you're on medications where pharmacogenomics matters, or you're interested in whether your nutrient absorption genetics differ from normal

2. Don't expect: It to reveal shocking disease predictions or replace actual health assessment based on blood work and physical health metrics

3. Use it for: Confirmation of why lifestyle modifications matter to you specifically, understanding medication metabolism, clarifying supplement forms that work best for your genetics

4. Combine with: Actual blood work (lipids, fasting glucose, vitamin D levels, etc.), clinical assessment, and family history. DNA testing is supplementary, not primary.

AlphaBiolabs' DNA health test covers the relevant markers for men over 40 and provides results in an accessible format: https://www.awin1.com/cread.php?awinmid=109866&awinaffid=2838304&clickref=&p=https%3A%2F%2Fwww.alphabiolabs.com

After 60 days of having this information, I'm not seeing DNA testing as a revolutionary health tool, but as a useful complement to other health assessment. The pharmacogenomics and nutrient metabolism data are the most actionable. The disease risk scores are less useful than knowing your actual blood work. Overall, it's worth doing once if you're interested in understanding your genetic health architecture, but don't expect it to be transformative.